Synopsis:- A mid-sized phosphatic fertilizer maker is nearly doubling its capacity and has locked in India’s largest long-term green ammonia supply deal, betting that scale and cheaper inputs will carry it past larger rivals over the next two years.
While fertilizer capacity expansion is a familiar industry theme, this Bhilwara-based company stands out with plans to increase capacity from 9 lakh MT to 15.6 lakh MT by FY28, making it India’s third-largest private-sector phosphatic fertilizer producer. Management expects the expanded capacity to generate over Rs.3,500 crore in annual revenue, supported by a strategic raw-material partnership and resilient quarterly performance.
With a market capitalisation of Rs. 6,473.44 crore, the shares of Madhya Bharat Agro Products Limited closed on Friday at Rs. 148.25 per share, up 0.99 percent from its previous closing price of Rs. 146.80 apiece. It is trading at a P/E of 41.51.
A Green Ammonia Deal That Could Reshape the Cost Curve
The company has signed a 10-year agreement to source 1.3 lakh MTPA of green ammonia under the government’s National Green Hydrogen Mission, and it’s being pitched as the largest such deal in the sector.
Management pegs the secured input cost at around Rs. 53 per kg against a global benchmark of roughly Rs. 110 per kg, a gap that, if it holds, would give the company a structural cost edge over importers of grey ammonia for years.
Ammonia is a core input for NPK and DAP complexes, so locking in supply at less than half the international price does more than protect margins during volatile freight or currency cycles; it changes how competitively the company can price its products against both domestic and imported fertilizer.
Building Toward India’s Third-Largest Private Phosphatic Platform
The headline expansion, from 9 lakh MT to roughly 15.6 lakh MT of fertilizer capacity by FY28, isn’t a single project but a series of them stacked across two states. The Dhule facility in Maharashtra alone is set to add 6.6 lakh MT of fertilizer capacity in two phases, targeted for October 2026 and October 2027, alongside expanded sulphuric acid and phosphoric acid capacity that deepens the company’s backward integration.
That integration matters here more than at many peers: producing its own sulphuric and phosphoric acid, rather than buying them in, gives the company more control over both cost and supply reliability as volumes scale up.
Q1 Numbers Show the Business Can Absorb Pressure
Revenue for the quarter came in at Rs. 416.3 crore, a modest 1.6 percent rise over the year-ago period, but the more telling numbers sit further down the statement. EBITDA rose 15.8 percent year-on-year to Rs. 65.9 crore, with margins expanding to 15.8 percent from 13.9 percent, and profit after tax grew 17 percent to Rs. 33 crore.
That combination, flat-ish revenue but sharply better profitability, came against a backdrop the company’s chairman described as marked by elevated raw material prices, geopolitical uncertainty, and a delayed monsoon.
Margin expansion in that kind of quarter usually points to either pricing discipline or a genuinely lower cost base, and given the ammonia deal now in place, it’s likely to be a bit of both going forward.
Structural Demand Gaps Still Favour Domestic Producers
Roughly 42 percent of India’s combined NPK and DAP demand is still met through imports, which leaves meaningful room for domestic capacity additions to take share rather than compete purely on price.
On top of that, government policy has been pushing farmers toward more balanced nutrient use rather than the historical overreliance on urea, a shift that favours phosphatic and potash-rich products over straight nitrogen fertilizers.
For a company whose expansion is concentrated almost entirely in phosphatic capacity, that policy direction lines up well with where the incremental capacity is being added.
What Should Investors Look Out For
Execution risk is the obvious one here: two large brownfield phases at Dhule still have to be commissioned on schedule, and delays or cost overruns on either could push back the revenue ramp management is counting on.
The stock also isn’t cheap at a P/E near 37, so any slippage in the expansion timeline or in green ammonia deliveries would likely hit the multiple as much as the earnings.
Revenue for this quarter, at 1.6 percent YoY, lagged the profit growth considerably, meaning the current beat leaned more on margin expansion than volume; that’s fine for one quarter but worth tracking if it continues once new capacity comes online and needs to be sold through.
Debt levels also bear watching given the scale of capex underway, since the payoff from the Dhule expansion and the green ammonia deal will take a couple of years to fully show up in earnings.
Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Trade Brains Technologies Private Limited or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.
